GHDX
Genomic Health, Inc.
GHDX
GHDX
Delisted
GHDX was delisted on the 7th of November, 2019.
124 hedge funds and large institutions have $968M invested in Genomic Health, Inc. in 2017 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 43 increasing their positions, 47 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
13% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 16
Holders
124
Holding in Top 10
3
Calls
$375K
Puts
–
Top Buyers
| 1 | +$73.9M | |
| 2 | +$10.5M | |
| 3 | +$4.93M | |
| 4 |
AL
AJO LP
Philadelphia,
Pennsylvania
|
+$4.74M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$3.99M |
Top Sellers
| 1 | -$10.8M | |
| 2 | -$2.94M | |
| 3 | -$1.8M | |
| 4 |
BIM
Bogle Investment Management
Newton Lower Falls,
Massachusetts
|
-$1.73M |
| 5 |
AllianceBernstein
Nashville,
Tennessee
|
-$1.46M |